HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

Healthcare Costs Causes Almost 40% of Americans to Make Sacrifices

A new West Health-Gallup poll taken in June shows that 38% of American adults had to make changes to their life to afford healthcare. The kinds and degree of sacrifices varied significantly amongst demographics, with impacts felt harder by lower-income Americans. One-fifth of people making less than […]

more info 08/17/2022View Related Articles
Bookmark and Share

Using Just-in-Time Clinical Trials to Address Disparities in Clinical Trial Representation

Finding and enrolling patients for clinical trials is one of the most difficult, time-consuming, and expensive parts of the drug development process. Ensuring that the patients represent the diversity of the population is even harder. In a new Targeted Oncology article, Kashyap Patel, MD, and […]

more info 08/17/2022View Related Articles
Bookmark and Share

Syndicated Report: Real-world Evidence Pharma Market Size Stakeholders Focus on Growth Strategies up to 2030

A new research report from Stratagem Market Insights, entitled “Real-world Evidence Pharma Market,” breaks down the current growth dynamics of the real-world evidence (RWE) pharma market and projects it out from 2022 to 2030. The report includes in-depth profiles of all the major players and covers […]

more info 08/17/2022View Related Articles
Bookmark and Share

Biden Signs Inflation Reduction Act

US President Biden signed the Democrat’s Inflation Reduction Act into law yesterday, August 16th. The sweeping partisan reconciliation bill includes drug pricing reforms that will allow Medicare to negotiate prices for a small set of expensive prescription drugs that will expand over the coming […]

more info 08/17/2022View Related Articles
Bookmark and Share

1st Zantac Case Against GSK Dropped by Plaintiff

Joseph Bayer, the plaintiff in the first case surrounding GSK’s Zantac has voluntarily dismissed his case against the company, citing personal health reasons. Bayer sued GSK and several others for esophageal cancer he developed that he and his care team attributed to the drug. So far, he has gotten […]

more info 08/17/2022View Related Articles
Bookmark and Share

Gilead Spends $455 Million for Rights to New Breast Cancer Drug in Asia

Hot off the heels of Gilead’s June approval for Troldelvy for metastatic triple-negative breast cancer (TNBC) drug in China, the company has agreed to a deal buying exclusive rights to sell the drug in Asia from the China-based Everest Medicines. This agreement gives Gilead global control of […]

more info 08/16/2022View Related Articles
Bookmark and Share

US Drug Launch Prices Higher Than Ever in 2022

A Reuters analysis has found that US launch prices for new drugs are approaching record highs. The study found this year’s median annual price of 13 drugs recently approved by the Food and Drug Administration (FDA) for chronic conditions is $257,000, with seven other drugs reaching the $200,000+ […]

more info 08/16/2022View Related Articles
Bookmark and Share

HHS in­spec­tor gen­er­al: NIH failed to ver­i­fy clin­i­cal tri­al re­sults were re­port­ed on time

Most NIH-fund­ed clin­i­cal tri­als with re­sults due in 2019 and 2020 did not meet fed­er­al re­port­ing re­quire­ments, the HHS in­spec­tor gen­er­al’s of­fice said in an au­dit re­leased Tues­day. The au­dit re­vealed that of 72 in­tra­mur­al and ex­tra­mur­al tri­als with re­sults due in 2019 […]

more info 08/16/2022View Related Articles
Bookmark and Share

Incoming ISPOR President Talks HEOR

Jan Elias Hansen, PhD, will soon take the reins as the ISPOR President for 2022-2023. In this month’s Value & Outcomes Spotlight, Hansen talks about her plans for the organization and her outlook on the field of health economics and outcomes research (HEOR). Her plan is to engage healthcare […]

more info 08/16/2022View Related Articles
Bookmark and Share

Carlyle and Abingworth Make First Major Biotech Investment

Launch Therapeutics, a joint project between the Carlyle Group and its recently acquired Abingworth, is funding the Australian biotech Opthea to the tune of $170 million. The deal will also provide clinical, regulatory, and commercial services. The deal is intended to help develop and launch […]

more info 08/16/2022View Related Articles
Bookmark and Share

Advancing Treatment for Immunological Diseases with Real-World Evidence and Data Analytics

Immune-mediated inflammatory diseases (IMIDs) are often difficult and expensive to treat, but new advances are being made with real-world evidence (RWE) and artificial intelligence (AI) by Jannen’s Immunology and R&D Data Science teams. Pulling real-world data (RWD) from a variety of sources, […]

more info 08/16/2022View Related Articles
Bookmark and Share

Australian Mining Billionaire Leans Into Biotech

Billionaires have leaned hard into biotech investments in recent years, backing small and large companies alike. Andrew “Twiggy” Forrest has joined the gang with his quarter-billion-dollar venture fund Tenmile. Forrest, whose fortunes come from his Australian mining business, has also acquired two […]

more info 08/15/2022View Related Articles
Bookmark and Share

Endpoints Webinar: How Merck is Building Biotech Labs of the Future – August 17th

The resources used by biotech labs often lag behind the new technological advances available to them. Digitalization, automation, robotics, and more could all help advance drug and device development if properly implemented. Unfortunately, dated systems often stand in the way of modernization. In a […]

more info 08/15/2022View Related Articles
Bookmark and Share

AJMC Interview: Dr Amila Patel on Designing Digital Health Solutions With the Patient in Mind

Digital health solutions have expanded access to care for millions, but not all groups have gotten the benefits of these technologies. In a new AJMC interview, Amila Patel, PharmD, chief clinical officer, Navigating Cancer discusses research presented at this year's American Society of Clinical […]

more info 08/15/2022View Related Articles
Bookmark and Share

Real-World Evidence and Real-world Data: Beyond Payer Decisionmaking

Although payer decision-making has been a key use of real-world evidence (RWE) and real-world data (RWD) in the healthcare space, there are far more avenues in which these resources can advance medicine. Agencies like the US Food and Drug Administration (FDA) are increasingly using RWE and RWD to […]

more info 08/15/2022View Related Articles
Bookmark and Share

Analysts Suggest Impact of Drug Pricing Reforms Would be Limited

Despite a litany of complaints and concerns from the industry, the new US drug pricing reform passed by the Democrats would have a marginal impact on pharma, according to analysts from the Bank of America and UBS. The legislation will allow Medicare to set Part D prices for some medications, 10 by […]

more info 08/15/2022View Related Articles
Bookmark and Share

Using Patient-Centered Digital Health Solutions to Improve Mental Health Outcomes

In recent years, digital health solutions have been developed for a variety of chronic conditions, but have yet to meet their promise. This “translation gap” represents a target for improving the state of digital health and bettering the health outcomes of patients. Mental healthcare, in particular, […]

more info 08/12/2022View Related Articles
Bookmark and Share

Meeting Patients’ Needs – the Role of the Provider

Taking on a more holistic approach to care requires consideration of a patient’s social determinants of health (SDoH). Amongst these factors is whether the patient’s basic needs are being met. A recent survey of 75 provider systems found that most providers are considering SDoH, but these efforts […]

more info 08/12/2022View Related Articles
Bookmark and Share

New MDCG Guidance on Conformity Assessment and Notified Bodies

The Medical Device Coordination Group (MDCG) has released a new guidance pertaining to conformity assessment and notified bodies. In part 1 of the guidance, the MDCG seeks to support the process of designating notified bodies in NANDO. In the second part, the guidance goes over the notification […]

more info 08/12/2022View Related Articles
Bookmark and Share

Inflation is Impacting Healthcare Decisions of Nearly 40% of Americans

The rising cost of healthcare has been exacerbated by inflation, impacting the healthcare decisions of almost 40% of US residents. A newly published West Health/Gallup shows healthcare cost increases have caused a large swath of the population to delay or miss healthcare, cut expenses, and incur […]

more info 08/12/2022View Related Articles
Bookmark and Share

Connecting Mental Healthcare with Primary Care to Improve Health Outcomes

Millions of people in the US who would benefit from mental healthcare are unable to do so due to a litany of barriers to access. Integrating primary care and mental healthcare could help lower barriers and get care to more patients. However, it will take a multipronged strategy from all stakeholders […]

more info 08/12/2022View Related Articles
Bookmark and Share

Crest Digital Health Targets Bipolar Disorder with Digital Health Solution

Patients with bipolar disorder often face poor health outcomes, especially when treatment plans are followed inconsistently or discontinued. Crest Digital Therapeutics, founded by Stephen Hamm, seeks to improve outcomes for people with bipolar disorder with its software platform that helps keep […]

more info 08/12/2022View Related Articles
Bookmark and Share

Endo Will File for Bankruptcy Due to Opioid Lawsuits “Imminently”

  Endo International signaled on Tuesday, August 11th, that bankruptcy is in the company’s immediate future. The announcement comes as the company faces thousands of lawsuits related to its role in the US opioid epidemic. The suits center around its drug Opana ER, which was pulled from […]

more info 08/11/2022View Related Articles
Bookmark and Share

Pharma Voice Woman of the Week: Miruna Sasu, President and CEO of COTA

On this week’s episode of the Woman of the Week by PharmaVoice podcast, host Taren Grom sits down with the CEO and president of COTA, Miruna Sasu. In the interview, Sasu talked about the power of real-world data (RWD) and real-world evidence (RWD) in driving future advances in oncology. When […]

more info 08/11/2022View Related Articles
Bookmark and Share

Essential Terms for UK Quality Regulations Post-Brexit

Many biotechs are struggling with the uncertain state of quality regulations in the Post-Brexit UK. Understanding the new regulatory processes and requirements begins with understanding the key terms in a new MasterControl article, Joanna Blair breaks down the top 11 terms you need to know to […]

more info 08/11/2022View Related Articles
Bookmark and Share

Pharma Preps Legal Strategy Against New US Drug Pricing Regulation

The US Senate’s newly passed drug pricing regulation will allow Medicare to cut the prices of a select number of drugs over the course of the decade. In response, pharma companies have begun prepping their legal objections to the rule. The industry will likely sue the Center for Medicare and […]

more info 08/11/2022View Related Articles
Bookmark and Share

Webinar: Confronting Care Inequities in Hospital Medicine

Although awareness of health disparities among marginalized racial and ethnic groups has grown in recent years, simply understanding the problem does not fix it. In a new webinar hosted by Becker’s Hospital Review, Greg Johnson, MD, SFHM, CEO of hospital medicine and chief diversity officer at Sound […]

more info 08/10/2022View Related Articles
Bookmark and Share

Pharma Marketing USA 2022 Article: Pharma Needs a Digital Reset Same as Above

Reaching the most important stakeholders in pharma, patients and their HCPs, requires breaking down operational silos and creating cross-functional teams. Doing so can help companies condense the science to actionable content that’s tailored for their audience. Building such teams starts with […]

more info 08/10/2022View Related Articles
Bookmark and Share

Exploring the Process for the Inflation Reduction Act Drug Price Negotiations

The Democrats’ Inflation Reduction Act includes a provision to let the US government negotiate the prices of certain medications for Medicare recipients. If passed, Medicare would be able to negotiate the price of 10 drugs in 2026 and another 20 by 2030. The slate of drugs targetted would include […]

more info 08/10/2022View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 186
  • Next Page

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

    No feed items found.

 
Syndicated Reports

Current and Future Analysis of Real World Data Market With New Business Strategies and Forecast by 2029 Parexel International Corporation, TriNetX LLC

Global Gene Therapy Report 2022-2031

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Economic & Related Consulting Service Revenues World Report & Database

 
White Papers

How Corporate Executives View Rising Health Care Cost and the Role of Government

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Build or Buy – Which Is the Right QMS Choice for Your Company?

Finland – A treasure trove for real-world evidence (RWE) research and innovation

HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists